Omni Health, Inc.
OMHE · OTC
1/31/2017 | 10/31/2016 | 7/31/2016 | 4/30/2016 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -1.05 | 0.46 | -0.00 | -0.00 |
| FCF Yield | -0.15% | -3.73% | 0.28% | -13.23% |
| EV / EBITDA | -1,209.21 | 189.52 | 1,041.74 | -8.31 |
| Quality | ||||
| ROIC | -1.05% | 0.75% | -0.51% | 325.19% |
| Gross Margin | 27.07% | 29.62% | 24.41% | -3.47% |
| Cash Conversion Ratio | 0.93 | 7.17 | 0.32 | 1.11 |
| Growth | ||||
| Revenue 3-Year CAGR | 113.64% | 118.34% | 88.15% | 167.77% |
| Free Cash Flow Growth | 74.73% | -2,280.89% | 102.69% | -937.58% |
| Safety | ||||
| Net Debt / EBITDA | -23.26 | 19.00 | 103.20 | 0.05 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 3.75 | 3.39 | 1.41 | 3.72 |
| Cash Conversion Cycle | 59.74 | 69.39 | 126.30 | 26.79 |